17th November 2017 – Aravax today signed a collaborative agreement with Stanford University in California. The Stanford research group, led by Professor Kari Nadeau, will collaborate with Aravax to further explore immunological responses to Aravax's revolutionary peanut allergy therapy, PVX108. Professor Kari Nadeau is one of the foremost experts in adult and pediatric allergy and asthma and is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanf